Do Randomized Controlled Trials Discuss Healthcare Costs?
G. Michael Allan, Christina Korownyk, Kate LaSalle et al. · 2010
Read Do Randomized Controlled Trials Discuss Healthcare Costs? by G. Michael Allan, Christina Korownyk, Kate LaSalle et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012318.txt.
Description
Michael Allan, Christina Korownyk, Kate LaSalle, and co-authors checked whether clinical trials talk about money, in PLOS ONE in 2010. Randomized controlled trials decide which treatments medicine adopts, yet health care costs, above all drug costs, dominate the budgets of the organizations that must pay for those treatments. A trial can prove a drug works while saying nothing about whether it is worth its price.
The team measured how often trial reports include costs, and what features make a trial more likely to mention them. If cost talk is rare, decision-makers are flying blind on value even when the science is clear. The paper gives medical journals and funders a baseline for demanding better.
Catalog record
| CREATOR | G. Michael Allan, Christina Korownyk, Kate LaSalle et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012318